The tumor microenvironment (TME) can secrete CXC chemokine ligands, attracting neutrophils, which possess high levels of chemokine receptors CXCR1 and CXCR2, to the site of the tumor, in a process called chemotaxis (8). The gene discussed is CXCR2; the disease is neoplasm.